StockData
RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

REGENTIS BIOMATERIALS LTD.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026
$1.48−0.01 (-0.67%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

REGENTIS BIOMATERIALS LTD. revenue by segment

No segment breakdown reported

Regentis Biomaterials does not break out revenue by segment, region or product in the tagged data of its filings for this period type.